Recent Antiphospholipid Syndrome News:

 

• Tissue injury—the biology: SLE-associated vascular disease and antiphospholipid syndrome
• Role of antiphospholipid antibodies in kidney disease: Risk factors, immunopathogenesis …
• Pharma heavyweights Pfizer and Roche up the ante in the battle for fat jabs – MSN
• A modest proposal: How television can ‘get us all on track’ regarding vaccines – Healio
• A Comprehensive Review of Venous Thromboembolism Risk Assessment Models for … – Frontiers
• Blood clots in the lungs: Pulmonary embolism explained -The Standard Health
• Adrenal Crisis Masquerading as Sepsis in a Patient With Autoimmune Multimorbidity
• I Was Incredibly Lucky—But Not Everyone Is: Hannah’s Story – National Blood Clot Alliance
• Birth and life as a hyper- or hypocoagulable state: above all, thrombin – Przegląd Lekarski
• Galapagos meets primary goal in phase 3 study for rare autoimmune disease asset
• Fibrin clot properties as the missing link between obstetric and thrombotic antiphospholipid syndrome
• Molecular stratification of antiphospholipid syndrome through integrative analysis of the …
• A Case of Large Subchorionic Hematoma | Cureus
• ശബരിമലയില്‍ ദര്‍ശനം നടത്തി ദിലീപ് | Dileep | Sabarimala – YouTube
• AI model helps diagnose often undetected heart disease from simple EKG
• LSU fellowship program targets rural rheumatologist shortage, seeks to expand – Healio
• Antiphospholipid Syndrome (APS) | University of Michigan Health
• Safeguarding fertility in an age of rising cancer diagnoses in young women – The Hindu
• The link between antiphospholipid syndrome and pregnancy outcomes: what you need to know
• Adapting haematology practices for effective management of blood disorders in pregnancy …
• What Factors Predict Thrombosis in aPL Antibody Positivity? – Medscape
• DOACs in PE: Need for Risk Stratification – Conexiant
• Antiphospholipid Syndrome (APS) Market is projected to reach – openPR.com
• SLE in Veterans Increases Maternal Pregnancy Risks – Optometry Advisor
• Aspirin Use Linked to Higher Bleeding, Thrombotic Risks in Patients with Antiphospholipid …
• The correlation of lupus anticoagulant and anticardiolipin antibodies with hematological …
• Antiphospholipid syndrome and recurrent pregnancy losses – ScienceDirect.com
• Bilateral Adrenal Hemorrhage in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
• Antiphospholipid Syndrome Market Size is anticipated to grow – openPR.com
• increase of monocyte/high-density lipoprotein cholesterol ratio precedes recurrent …
• How can nursing homes protect more patients from infections? – Michigan Medicine
• Eliquis doesn’t cause as much bruising as Coumadin – PressReader
• Cardiovascular risk factors and target attainment a concern in APS | springermedicine.com
• America doesn’t have enough hospital beds. This could help | University of Michigan Health
• Renal, Hepatic and other Intraabdominal Manifestations in the Antiphospholipid Syndrome
• Too Little CV Risk Factor Control Seen in Patients With APS – Medscape
• Truvian Receives FDA 510(k) Clearance for Multimodal Benchtop Analyzer | 360Dx
• Prior mental health diagnosis may predict neuropsychiatric outcomes in childhood lupus
• VNRX: 3Q 2025 results reported; Revenues & EPS above our expectations; cost cutting very …
• Hypertrophic Cardiomyopathy (HCM) | University of Michigan Health
• Terrible APS (TrAPS) – A newly defined variant of severe APS – Frontiers
• Catastrophic antiphospholipid syndrome following surgery for Libman–Sacks endocarditis
• Ianalumab shows ‘meaningful, disease-modifying results’ vs placebo in Sjögren’s – Healio
• Clinical presentation of antiphospholipid syndrome – ScienceDirect.com
• BREAKING STUDY: COVID-19 “Vaccines” Linked to Multiple Sclerosis, Lupus, Type 1 …
• Blood Test Reveals Risks in Antiphospholipid Syndrome, SLE – Medscape
• Reproductive health outcomes in rheumatic diseases highlighted at ACR Convergence 2025 – Healio
• Thrombophilia Industry Report: Competitive Landscape and Future Prospects
• Massive Pulmonary Embolism in the Postpartum Period as the First Manifestation of …
• Inhibition of FKBP5 alleviates obstetric antiphospholipid syndrome by regulating … – Nature

Antiphospholipid Syndrome News:

 

• Nine research updates in thrombosis treatment, surveillance and risk prediction.

• Antiphospholipid syndrome. This review summarizes the main knowledge on the clinical and therapeutic aspects of this syndrome.

• Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Thrombotic complications are the most common cause of death in APS.

• Autoantibodies may be a risk factor for heart attack

• Heart attack: New finding may change the face of treatment

• Hughes syndrome (antiphospholipid syndrome) and the nervous system.

• When autoimmune diseases exert neuro-ophthalmic effects

• Catastrophic antiphospholipid syndrome: The current management approach.

•  2016 review on catastrophic antiphospholipid syndrome.

• Antiphospholipid syndrome in obstetrics.

• Pregnancy and APS: Results Look Encouraging

• The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome

• Anticoagulating patients with high-risk acquired thrombophilias.

• Infectious, Noninfectious Postoperative Complications More Frequent in Patients With SLE

• Catastrophic antiphospholipid syndrome: The current management approach.

• Rapidly progressive coronary artery disease as the first manifestation of antiphospholipid syndrome.  case report
• C-sections raise blood clot risk; protection urged in new recommendation from American College of Obstetricians and Gynecologists. CBS News,
• Myasthenia gravis  is sometimes found in conjunction with antiphospholipid syndrome with: A case report
• Primary antiphospholipid syndrome should be considered as a possible cause of repeated stent thrombosis. Journal of Cardiology Cases.
  
• Good news for prospective mothers with antiphospholipid syndrome? –  Journal of Postgraduate Medicine
• New study suggests that long-term anticoagulation with low molecular weight heparin (LMWH) may be a safe and effective alternative for APS patients who had not responded to warfarin (Coumadin) – Annals of Rhematic Diseases

• Rheumatologist Dr. Doruk Erkan talks about Antiphospholipid Syndrome (APS), the disorder that caused my stroke, in this Q&A with the Hospital for Special Surgery. Read it to learn more about APS. – Dr. Doruk Erkan, Rheumatologist

• Antiphospholipid syndrome plus rheumatic fever: A higher risk factor for stroke? – MD Linx

• Preeclampsia: New Research Reveals Why Preeclampsia More Likely For Some Women – Mattason’s Review

• Antiphospholipid syndrome: endocrinologic manifestations and organ involvement